* sleep disorders
** GABA neuropharmacology
*** GABA role
inhibitory neurotransmitter
*** GABAergic receptors
**** GABA_A
- Have chloride channels associated with in the receptor
- Modulated by GABA, Benzodiazepines, Barbiturates
***** agonists
****** drugs
- zolpidem
- zaleplon
- eszopiclone
****** pharmacology
- enhances membrane hyperpolarization similar to benzodiazepines
- doesn’t cause anxiolysis, muscle relaxation, or amnesia
**** GABA_B
***** agonists
Baclofen
***** antagonists
flumazenil
** drug classes :l:
*** benzodiazepines
**** drugs :l:
***** Alprazolam
****** brand
Xanax
***** Chlordiazepoxide 
****** brand
Librium
***** Clorazepate 
****** brand
Tranxene
***** Clonazepam 
****** brand
Klonopin
***** Diazepam 
****** brand
Valium
***** Estazolam 
****** brand
ProSom
***** Flurazepam 
****** brand
Dalmene
***** Lorazepam 
****** brand
Ativan
***** Midazolam 
****** brand
Versed
***** Quazepam 
****** brand
Doral
***** Temazepam 
****** brand
Restoril
***** Triazolam 
****** brand
Halcion
**** interactions
***** severe liver impairment
- oxazepam
- temazepam
- lorazepam
**** drugs by duration of action
***** ultrashort acting drugs 6h
- triazolam
- midazolam
*** barbituates :l:
**** Amobarbital 
***** brand
Amytal
**** Mephobarbital 
***** brand
Mebaral
**** Pentobarbital 
***** brand
Nembutal
**** Phenobarbital 
***** brand
Luminal
**** Secobarbital 
***** brand
Seconal
*** GABA_A agonists aka “Z Hypnotics” :l:
**** Eszopiclone 
***** brand
Lunesta
***** indication
effective for maintaining sleep---sencodary to longer duration
**** Zaleplon 
***** brand
Sonata
**** Zolpidem 
***** brand
Ambien
*** Melatonin receptor agonists :l:
**** Ramelteon 
***** brand
Rozerem
***** MOA :ignore:
M1 and M2 receptor antagonist
***** adverse effects
- worsening depression
- psychosis
*** 5-HT1A-partial agonist :l:
**** Buspirone 
***** brand
BuSpar
*** orexin receptor antagonist :l:
**** suvorexant
***** brand
Belsomra
***** MOA
orexin (hypocretin) is released from the hypothalamus to promote wakefulness or arousal
*** sedating antipsychotics :l:
**** olanzapinep
***** brand
Zyprexa
**** quetiapine
***** brand
Seroquel
** obstructive sleep apnea
*** diagnosis
polysomnography; 5-15+ events/hr
*** non-pharmacologic
Positive Airway Pressure is the gold standard
*** pharmacologic
**** drugs :l:
***** modafinil (Provigil)
***** armodafinil (Nuvigil)
**** indication
Residual excessive daytime sleepiness despite effective PAP treatment
** narcolepsy
*** first line :l:
**** modafinil 200mg qAM, max 400mg/day
**** armodafinil 150-250 mg qAM
** cataplexy
*** first line :l:
sodium oxybate (GHB) 2.25-4 g/HS (powder); repeat dose in 4 hoursp
** restless leg syndrome
*** causes
low dopamine; treatment is dopamine agonists
*** drugs
**** dopamine agonists :l:
***** Ropinirole
****** brand
Requip
***** Pramiprexole
****** brand
Miraxpex 
***** Levodopa/Carbidopa
****** brand
Sinemet
***** Rotigotine 
**** anticonvulsants :l:
***** Gabapentin Enacarbil
****** brand
Horizant
***** Gabapentin
****** brand
Neurontin 
***** Pregabalin
****** brand
Lyrica 
* epilepsy
** neuropharmacology
*** glutaminergic receptors
- N-methyl-D-aspartate (NMDA Receptors)
- AMPA (alpha-amino-3-hydroxymethyl-4-isoxazolepropionic acid) Receptors
- Kainate Receptors
** causes
- neurologic diseases
- heredity
- gene defects
** classes
*** partial seizures :l:
**** simple partial
preservation of consciousness
**** complex partial
impaired consciousness lasting 30 seconds - 2 minutes
**** partial with secondarily generalized tonic-clonic seizure
- simple or complex partial seizure with loss of consciousness and tonicity (sustained contractions) followed by periods of clonicity (relaxation)
- typically lasts 1-2 minutes
*** generalized seizures :l:
**** Generalized tonic-clonic (grand mal) seizures
**** Absence (petit mal) seizures
abrupt onset of impaired consciousness; e.g., staring off into the void for 30 seconds
**** myoclonic seizure
A brief (perhaps a second), shock like contraction of muscles that may be restricted to part of one extremity or may be generalized
**** Tonic seizures
**** Atonic seizures
**** Clonic and myoclonic seizures
**** Infantile spasm
** indication → drugs
*** status epilepticus
- diazepam
- lorazepam
** drug classes
*** newer agents :l:
**** Voltage gated calcium channels :l:
***** Gabapentin
****** MOA
Bind selectively to high affinity to Ca2+ channel subunit α2δ-1 protein in cortical membrane
***** Pregablin
****** MOA
Bind selectively to high affinity to Ca2+ channel subunit α2δ-1 protein in cortical membrane
**** GABA uptake/GABA-T inhibitor
- Tiagabine
- Vigabatrin
**** NMDA antagonist
Felbamate
**** AMPA/Kainate receptor antagonist
Topiramate
**** HCN channel activity enhancer
Lamotrigine
**** SV2A protein ligand
Levitiracetam
**** Ca and Na channels blocker
Zonisamide
**** Voltage Gated Na Channels
Lacosamide
**** Carbonic anhydrase inhibitor
Acetazolamide
*** older agents :l:
**** Hydantoins :l:
***** Phenytoin
****** MOA
- Limits the repetitive firing of action potentials evoked by a sustained depolarization
- Selectively, slows the rate of recovery of voltage-activated Na+ channels from inactivation, an action that is both voltage- and use-dependent (without affecting GABA or glutamate) 
****** interactions
Valproate competes for protein binding sites and inhibits phenytoin metabolism, resulting in marked and sustained increases in free phenytoin
***** Phosphenytoin
**** Benzodiazepines :l:
***** clonazepam
****** brand
Klonopin
***** clorazepate
****** brand
Tranxene
***** diazepam
****** brand
Valium
****** indication
status epilepticus
***** lorazepam
****** brand
Ativan
****** indication
status epilepticus
**** Barbiturates :l:
***** Phenobarbital
Relatively low toxicity, is inexpensive, and is still one of the more effective and widely used drugs for control of generalized tonic-clonic and partial seizures
****** indication
generalized tonic-clonic and partial seizures
****** nonindications
abscence seizures
****** MOA
Potentiation of GABA_A receptor-mediated synaptic inhibition
****** adverse effects
sedative effect htat disturbs behavior in children
**** Iminostilbenes :l:
***** Carbamazepine
****** MOA
- Limits the repetitive firing of action potentials evoked by a sustained depolarization of mouse spinal cord or cortical neurons maintained in 
- Selectively, slows the rate of recovery of voltage-activated Na+ channels from inactivation 
- Carbamazepine metabolite, 10,11-epoxycarbamazepine, also limits sustained repetitive firing at therapeutically relevant concentrations
****** indication
- trigeminal and glossopharyngeal neuralgias
- generalized tonic clonic
- simple and complex partial seizures
***** Oxcarbazepine
****** indication
- partial seizures
**** Succinimides :l:
***** Ethosuximide
****** indication
/only/ absence seizures
**** valproic acid
***** indication
broad spectrum:
- absence
- partial seizures
- generalized tonic-clonic seizures
- myoclonic
